EB
IONS icon

Eastern Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Eastern Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.8K Hold
300
– – ﹤0.01% 740
2026
Q1 		$22.5K Hold
300
– – ﹤0.01% 697
2025
Q4 		$23.7K Hold
300
– – ﹤0.01% 697
2025
Q3 		$19.6K Hold
300
– – ﹤0.01% 730
2025
Q2 		$11.9K Hold
300
– – ﹤0.01% 738
2025
Q1 		$9.05K Buy
+300
New +$9.82K ﹤0.01% 798

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Eastern Bank's IONS Position: Q2 2026 in Review

Eastern Bank held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 300 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #740.

Eastern Bank first reported a position in IONS in Q1 2025 and has held it in 6 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Eastern Bank held 300 shares of Ionis Pharmaceuticals worth $23.8K as of Q2 2026.
  • Eastern Bank left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #740 holding.
  • Eastern Bank first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.